CVE-2019-13157
nsGreen.dll in Naver Vaccine 2.1.4 allows remote attackers to overwrite arbitary files via directory traversal sequences in a filename within nsz archive.
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (1.65%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
nsGreen.dll in Naver Vaccine 2.1.4 allows remote attackers to overwrite arbitary files via directory traversal sequences in a filename within nsz archive.
- CVSS 3.1
- 7.5 HIGHCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N
- EPSS
- 1.65% probability · 76th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-22
- Affected
- naver/vaccine
- Source
- cve@navercorp.com
EPSS 1.7% since 27 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- https://cve.naver.com/detail/cve-2019-13157Vendor Advisory
- https://cve.naver.com/detail/cve-2019-13157Vendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.